BantingFG, BestCH, CollipJB, CampbellWR, FletcherAA.Pancreatic extracts in the treatment of diabetes mellitus: Preliminary report. CMAJ1922;12:141–146.
2.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med1993;329:977–986.
3.
FarneyAC, ChoE, SchweitzerEJ, DunkinB, PhilosopheB, ColonnaJ, JacobsS, JarrellB, FlowersJL, BartlettST.Simultaneous cadaver pancreas living-donor kidney transplantation: A new approach for the type 1 diabetic uremic patient. Ann Surg2000;232:696–703.
4.
HumarA, KandaswamyR, GrangerD, GruessnerRW, GruessnerAC, SutherlandDER.Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg2000;231:269–275.
ShapiroAMJ, LakeyJRT, RyanEA, KorbuttGS, TothEL, WarnockGL, KnetemanNN, RajotteRV.Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med2000;343:230–238.
7.
RyanEA, LakeyJRT, RajotteRV, KorbuttGS, KinT, ImesS, RabinovitchA, ElliottJF, BigamD, KnetemanNM, WarnockGL, LarsenI, ShapiroAMJ.Clinical outcomes and insulin secretion after islet transplantation with the Edmonton Protocol. Diabetes2001;50:710–719.
8.
ServiceFJ, MolnarGD, RosevearJW, AckermanE, GatewoodLC, TaylorWF.Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes1970;19:644–655.
9.
VasquezEM.Sirolimus: A new agent for prevention of renal allograft rejection. Am J Health Syst Pharm2000;57:437–448.
10.
GruessnerRW.Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Clin Transplant1997;11:299–312.
11.
LauritzenT, Frost-LarsenK, LarsenH-W, DeckertT.Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet1983;i:200–204.
